Antimicrobial Resistance Partnership Hub launched in China

  22 May 2019

The UK-China AMR Programme is a collaborative research and training programme that will bring together leading experts in the UK and China to tackle antibiotic resistance, the type of AMR identified as most critical to human health.

The programme will conduct research that will deliver key evidence that is required to enhance the success of antibiotic resistance reduction strategies in China. Three linked projects will investigate behavioural, economic and environmental aspects of antibiotic resistance. This will involve measuring human exposure to antibiotics (from environmental and livestock sources) and documenting patterns of antibiotic use in health care; designing a tailored intervention for China and produce evidence-based recommendations to modify antibiotic prescribing behaviour, in order to reduce antibiotic consumption; and estimating the cost-effectiveness of different intervention strategies, as well as the economic burden of AMR to the country.

Further reading: NIHR
Effective Surveillance   Healthy Patients   Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!